Results 141 to 150 of about 153,965 (262)
Core temperature measurement methods and their accuracy in pediatric intensive care units: a narrative review. [PDF]
Chen H, Huang H, Ning J, Li Y, Qiao L.
europepmc +1 more source
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source
Changes in Academic Standardized Testing After Pediatric Intensive Care.
Foster CC +9 more
europepmc +1 more source
Evaluation of visitation policies and family information practices in pediatric intensive care units in Turkey: a national survey. [PDF]
Emeksiz S +4 more
europepmc +1 more source
Efficacy, safety and cost‐effectiveness of CAR‐T therapy
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher +7 more
wiley +1 more source
Navigating Culture and Crisis: Saudi Mothers' Experiences of Family-Centered Care in Pediatric Intensive Care Units-A Qualitative Study. [PDF]
Alshehri WM +9 more
europepmc +1 more source
Aims Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.
Gianluca Gazzaniga +20 more
wiley +1 more source
Clinical and Epidemiological Characteristics of Ventilator-associated Pneumonia in Pediatric Intensive Care Units. [PDF]
Babai S, Parastegari M, Zibanejad N.
europepmc +1 more source
Abstract Background and Purpose Drug–drug interactions (DDIs) are associated with an increased risk of adverse drug reactions (ADRs). Hospitalized children are particularly vulnerable to DDIs and ADRs due to polypharmacy, frequent use of unlicensed or off‐label medications, and dosing regimens often extrapolated from adult data.
Emilie Laval +6 more
wiley +1 more source

